Strengthening FDA’s Regulatory Readiness: Implementing Lessons Learned from the COVID-19 Pandemic

Publication

Strengthening FDA’s Regulatory Readiness: Implementing Lessons Learned from the COVID-19 Pandemic

Abstract

The Senate Committee on Health, Education, Labor and Pensions issued a Minority Oversight Record on FDA expedition of the development and authorization of COVID-19 vaccines, therapeutics, and tests. The record discussed the challenges and congressional action taken to enhance capacity and supply chain resilience for future public health emergencies.